Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

The mood is better than the numbers suggest. The doom-loop panic of March and April is behind us, even though the XBI has ...

KKR & Co.-backed venture capital firm Catalio Capital Management gathered more than $400 million for its latest fund, a ...

HQH offers high yields with a biotech and small/mid-cap tilt, but relies on capital payouts, making it less tax efficient and ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

As artificial intelligence continues to redefine industries, its most transformative impact in biotech is happening b ...

"If a company isn't IPO-ready, it better be M&A-ready," says Nanna Luneborg of Forbion Capital Partners. She and co-founder Sander Slootweg sit down with Bloomberg Intelligence analyst Sam Fazeli to ...

The head of the EU's pharmaceutical lobby has called for the creation of a life sciences-focused stock market in Europe, ...

The NATO Innovation Fund has made its first investment in a biotechnology company, it said on Monday, seeking to enhance ...

The Union government has approved Rs 20.55 crore for a biotech incubation centre in Raipur, aimed at fostering innovation and ...

Top Create Biotech has filed for an initial public offering. The biotechnology company said Wednesday that it intends to list shares under the ticker symbol TCBG on the Nasdaq Capital Market. Top ...